Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Multiple Endocrine Neoplasia Type 1
×
evolocumab
×
Clear all
Filters
2
NCT03872401
2025-11-10
VESALIUS-CV
Amgen
Phase 3
Completed
12,301 enrolled